Evidence Supporting the Shift Toward Radioembolization as the Primary Bridging Therapy for Liver Transplant Candidates With Hepatocellular Carcinoma in the United States
American Journal of Roentgenology · 10.11.2026 · 1-1
DOI: 10.2214/ajr.26.35001 ↗Kurz gefasst
Kommentar in der Zeitschrift American Journal of Roentgenology, online erschienen am 10.11.2026. Verfasst von Ken Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065.
Zitieren
APA
Zhao, K., & Yarmohammadi, H. (2026). Evidence Supporting the Shift Toward Radioembolization as the Primary Bridging Therapy for Liver Transplant Candidates With Hepatocellular Carcinoma in the United States. American Journal of Roentgenology, 1-1. https://doi.org/10.2214/ajr.26.35001
Vancouver
Zhao K, Yarmohammadi H. Evidence Supporting the Shift Toward Radioembolization as the Primary Bridging Therapy for Liver Transplant Candidates With Hepatocellular Carcinoma in the United States. American Journal of Roentgenology. 2026:1-1. doi:10.2214/ajr.26.35001
BibTeX
@article{Zhao2026,
author = {Zhao, Ken and Yarmohammadi, Hooman},
title = {Evidence Supporting the Shift Toward Radioembolization as the Primary Bridging Therapy for Liver Transplant Candidates With Hepatocellular Carcinoma in the United States},
journal = {American Journal of Roentgenology},
year = {2026},
pages = {1--1},
doi = {10.2214/ajr.26.35001}
}
EUVIMED